EUVIMEDEUVIMED entdecken
Crossref

Co-Delivery of paclitaxel and doxorubicin in folate-Targeted pluronic/ploy (D,L-lactide- b -glycolide) polymersomes

Tian Yi Wu, Wen Jie Cao, Zi Ling Li, Yan Chun Gong, Xiang Yuan Xiong iD

Journal of Biomaterials Applications · 2023

DOI: 10.1177/08853282231156316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2023. Verfasst von Tian Yi Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Jiangxi Science and Technology Normal University, Nanchang, China. Hauptthemen laut MEDLINE: Paclitaxel, Ovarian Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs with different solubility can be selectively embedded into polymersomes with the hydrophilic core and hydrophobic bilayer. Novel folate-targeted Pluronic/poly (D,L-lactide- b-glycolide) polymersomes were constructed and used for the co-delivery of paclitaxel (PTX) and doxorubicin (DOX) to improve their inhibitory effect over cancer cells. The particle size of blank polymersomes was mainly distributed below 125 nm. The release of PTX and DOX from polymersomes showed an initial burst release followed by a sustained and slow release. The in vitro cytotoxicity data showed that the targeted co-loaded polymersomes (PTX&DOX FA-Ps) exhibited better inhibitory effect than single-loaded polymersomes and free drugs did. Furthermore, PTX&DOX FA-Ps showed the synergistic therapeutic effect over OVCAR-3 cancer cells. The cellular uptake results also showed that folate modified polymersomes had excellent targeting performance. Therefore, the folate-targeted Pluronic/poly (D,L-lactide- b-glycolide) polymersomes have potential application value as novel drug carriers to co-deliver PTX and DOX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelOvarian NeoplasmsHumansFemalePoloxamerApoptosisFolic AcidCell Line, TumorDoxorubicinDrug CarriersDrug Delivery SystemsDioxanes

Stichwörter der Autor:innen

Polymersomeco-deliverydoxorubicinfolatepaclitaxel

Substanzen

PaclitaxelPoloxamerFolic AcidDoxorubicinDrug CarriersdilactideDioxanes

Autor:innen und Institutionen

  • School of Life Science, Jiangxi Science and Technology Normal University, Nanchang, China.

ORCID-Profile: Xiang Yuan Xiong

Förderung

  • Jiangxi Provincial Natural Science Foundation

Zitieren

APA

Wu, T. Y., Cao, W. J., Li, Z. L., Gong, Y. C., & Xiong, X. Y. (2023). Co-Delivery of paclitaxel and doxorubicin in folate-Targeted pluronic/ploy (D,L-lactide- b -glycolide) polymersomes. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282231156316

Vancouver

Wu TY, Cao WJ, Li ZL, Gong YC, Xiong XY. Co-Delivery of paclitaxel and doxorubicin in folate-Targeted pluronic/ploy (D,L-lactide- b -glycolide) polymersomes. Journal of Biomaterials Applications. 2023. doi:10.1177/08853282231156316

BibTeX
@article{Wu2023,
  author = {Wu, Tian Yi and Cao, Wen Jie and Li, Zi Ling and Gong, Yan Chun and Xiong, Xiang Yuan},
  title = {Co-Delivery of paclitaxel and doxorubicin in folate-Targeted pluronic/ploy (D,L-lactide- b -glycolide) polymersomes},
  journal = {Journal of Biomaterials Applications},
  year = {2023},
  doi = {10.1177/08853282231156316}
}
Kostenlos starten →